Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation

Yongwhan Lim; Min Chul Kim; Kye Hun Kim; In-Seok Jeong; Yong Soo Cho; Yoo Duk Choi; Jong Eun Lee

doi:10.3389/fcvm.2021.758996

Frontiers in Cardiovascular Medicine (Oct 2021)

Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation

Yongwhan Lim,
Min Chul Kim,
Kye Hun Kim,
In-Seok Jeong,
Yong Soo Cho,
Yoo Duk Choi,
Jong Eun Lee

Affiliations

Yongwhan Lim: Department of Cardiovascular Medicine, Chonnam National University Medical School/Hospital, Gwangju, South Korea
Min Chul Kim: Department of Cardiovascular Medicine, Chonnam National University Medical School/Hospital, Gwangju, South Korea
Kye Hun Kim: Department of Cardiovascular Medicine, Chonnam National University Medical School/Hospital, Gwangju, South Korea
In-Seok Jeong: Department of Cardiothoracic Surgery, Chonnam National University Medical School/Hospital, Gwangju, South Korea
Yong Soo Cho: Department of Emergent Medicine, Chonnam National University Hospital, Gwangju, South Korea
Yoo Duk Choi: Department of Pathology, Chonnam National University Medical School, Gwangju, South Korea
Jong Eun Lee: Department of Radiology, Chonnam National University Hospital, Gwangju, South Korea

DOI: https://doi.org/10.3389/fcvm.2021.758996
Journal volume & issue: Vol. 8

Abstract

Read online

Recently, myocarditis following messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination has become an important social issue worldwide. According to the reports so far, myocarditis related to mRNA COVID-19 vaccination is rare and usually associated with a benign clinical course without intensive care or any sequelae of fulminant myocarditis. Here, we report a case of acute fulminant myocarditis and cardiogenic shock after the mRNA COVID-19 vaccination, requiring extracorporeal cardiopulmonary resuscitation. Clinicians should keep in mind the possibility of progression to fulminant myocarditis in patients who presented with suggestive symptoms or signs of myocarditis after the COVID-19 vaccination.

Published in Frontiers in Cardiovascular Medicine

ISSN: 2297-055X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.frontiersin.org/journals/cardiovascular-medicine

About the journal

Abstract

Keywords